MedTrace Logo

Combined Strength and Plyometric Training in Sanda Athletes

NCT07617831 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-06-01

No results posted yet for this study

Summary

This randomized controlled trial evaluated the effects of an 8-week combined strength and plyometric training program on lower-limb performance and neuromuscular function in male Sanda athletes. Thirty male Sanda athletes were randomly assigned to a strength training group or a combined strength and plyometric training group. Both groups trained three times per week for 8 weeks. Outcomes were assessed before and after the intervention and included standing long jump, countermovement jump, hexagon test, reactive strength index, lower-limb vertical stiffness, and lead-leg Sanda roundhouse kick attack time.

Conditions

  • Athletic Performance; Neuromuscular Function; Lower-Limb Performance;Sanda

Interventions

BEHAVIORAL

Strength Training

The strength training intervention consisted of periodized resistance training over 8 weeks, with progressive increases in intensity based on one-repetition maximum. Exercises included lower-limb resistance exercises such as squat, deadlift, and lunge variations.

BEHAVIORAL

Combined Strength and Plyometric Training

The combined training intervention consisted of the same periodized strength training program as the strength training group plus a plyometric training component. Plyometric exercises were performed on non-slip rubber flooring, and jump height was monitored before each session.

Sponsors & Collaborators

  • Mingjie Hu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-20
Primary Completion
2026-04-15
Completion
2026-04-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07617831 on ClinicalTrials.gov